Search results
Results from the WOW.Com Content Network
In 2018, HHS proposed a new rule that would reduce reimbursement rates for only 340B hospitals, but did not conduct a survey of hospital acquisition costs. In its final rule, HHS retained the approximately 106 percent reimbursement rate for non-340B hospitals, and established a 77.5 percent reimbursement rate for 340B hospitals.
HCUP Logo. The Healthcare Cost and Utilization Project (HCUP, pronounced "H-Cup") is a family of healthcare databases and related software tools and products from the United States that is developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality (AHRQ).
Through the IEA, HHS directs and oversees current federal health programs at the regional and tribal levels. Headquarters Staff – assists the HHS Secretary in developing policies related to state and local government relations. Tribal Affairs – serves as the point of contact for HHS regarding HHS programs on Indian reservations.
The insurer pays the doctor, hospital or lab based on negotiated, in-network rates between the two parties. Critics of this fee-for-service payment method says it rewards quantity over quality.
Dental treatments (filings, X-rays, cleaning, braces) Doctor's office visits. Fertility treatments. Lab fees. Physical therapy. Prescription medications. Psychiatric care provided by a licensed ...
For scale, cutting administrative costs to peer country levels would represent roughly one-third to half the gap. A 2009 study from Price Waterhouse Coopers estimated $210 billion in savings from unnecessary billing and administrative costs, a figure that would be considerably higher in 2015 dollars. [50] Cost variation across hospital regions.
The Health Resources and Services Administration (HRSA) is an agency of the U.S. Department of Health and Human Services located in North Bethesda, Maryland.It is the primary federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable.
Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, on Friday raised concerns about Robert F. Kennedy Jr.’s agenda for the Department of Health and Human Services.